Not all Nutritional Supplements for Age Related Macular Degeneration (ARMD) contain proven formulations according to NIH trials AREDS and AREDS2


Not all Nutritional Supplements for Age Related Macular Degeneration (ARMD) contain proven formulations according to NIH trials AREDS and AREDS2

This is shocking to read, but only the below nutritional supplements for macular degeneration contained correct formulations according to important NIH based studies for ARMD called AREDS and AREDS2.

1. Bausch + Lomb’s: PreserVision Eye Vitamin AREDS Formula Tablets, 
2. Bausch + Lomb’s: PreserVision Eye Vitamin AREDS Formula Soft Gels, 
3. Bausch + Lomb’s: PreserVision AREDS2 Formula.
4. Alcon’s ICaps AREDS Formula supplement 
Volume 122, Issue 3, March 2015, Pages 595–599
Original article

Ocular Nutritional Supplements : Are Their Ingredients and Manufacturers’ Claims Evidence-Based?


Purpose

To compare ingredients contained in top-selling brands of ocular nutritional supplements with the Age-Related Eye Disease Study (AREDS) and AREDS2 formulae and investigate the validity of claims made by manufacturers of leading brands of ocular nutritional supplements.

Design

Descriptive.

Participants

None.

Methods

We examined the 5 top-selling brands of ocular nutritional supplements in the United States according to dollar sales tracked by SymphonyIRI (Waltham, MA) from June 2011 to June 2012. We reviewed the ingredients and manufacturer claims of 11 ocular nutritional supplements on the companies’ consumer information websites; the ingredients were compared with those contained in the AREDS and AREDS2 formulae.

Main Outcome Measures

Proportion of ocular nutritional supplements that contained the same ingredients, in the same doses, as the AREDS or AREDS2 formula; proportion of nutritional supplements with unsubstantiated claims made by the manufacturer.

Results

All of the ocular nutritional supplements contained the ingredients from the AREDS or AREDS2 formula; 36% (4/11) of the supplements contained equivalent doses of AREDS or AREDS2 ingredients; 55% (6/11) included some information about the AREDS on their consumer information websites. Product descriptions from 4 of the 11 supplements (36%) stated that the supplements were important to maintain general eye health; none of these supplements duplicated the AREDS or AREDS2 formula. All the individual supplements claimed to “support,” “protect,” “help,” or “promote” vision and eye health, but none specified that there is no proven benefit in using nutritional supplements for primary prevention of eye disease.

Conclusions

The majority of top-selling ocular nutritional supplements did not contain the identical ingredient dosages of the AREDS or AREDS2 formula and had product description claims that lacked level 1 evidence, underscoring the importance of ophthalmologists educating their patients on the evidence-based role of nutritional supplements in the management of eye health.

Abbreviations and Acronyms

  • AMDage-related macular degeneration
  • AREDSAge-Related Eye Disease Study
Among the 59% of adults in the United States who take dietary supplements, 7% use a supplement for eye health.1 The Age-Related Eye Disease Study (AREDS) demonstrated that routine supplementation with certain nutrients in people with intermediate or advanced age-related macular degeneration (AMD) in 1 eye or intermediate AMD in both eyes reduces the risk of worsening AMD and severe vision loss by 25% over a 6-year period.2 The AREDS2 demonstrated that a certain combination of carotenoids (lutein and zeaxanthin) is a safe and effective alternative for beta-carotene, an ingredient in the original AREDS formula that has been associated with lung cancer in smokers.3 At present, there is insufficient evidence to support routine use of nutritional supplements for primary prevention of eye diseases such as AMD and cataracts.4 and 5 However, eye supplements continue to be marketed as crucial to maintaining eye health and vision, and sales continue to increase with an annual growth rate of 5%.6 Moreover, recent studies have shown that supplementing the diet of healthy adults with vitamins and minerals had no clear benefit with respect to all-cause mortality, cardiovascular disease, or cancer, and may even be associated with higher mortality.7 and 8 The current study compares ingredients contained in top-selling brands of ocular nutritional supplements with the AREDS and AREDS2 formulae and investigates the validity of claims made by manufacturers of leading brands of ocular nutritional supplements.

Methods

We examined the 5 top-selling brands of ocular nutritional supplements in the United States according to dollar sales tracked by SymphonyIRI (Waltham, MA) through U.S. supermarkets, grocery stores, drugstores, and mass merchandisers (excluding Walmart) from June 2011 to June 2012.9 Packaged Facts, a publisher of market research, compiled the sales data from SymphonyIRI and ranked the top 10 eye supplement brands.9 This publicly available Packaged Facts market report was obtained from the Harvard Business School Library’s MarketResearch.com academic subscription. PreserVision (Bausch & Lomb, Rochester, NY; ranked 1/10), Ocuvite (Bausch & Lomb) (ranked 2/10), and Ocuvite PreserVision (Bausch & Lomb) (ranked 5/10) supplements were categorized in our study into PreserVision or Ocuvite on the basis of Bausch & Lomb’s 2 brand subcategories. ICaps AREDS (ranked 4/10) sales were tracked separately from other ICaps (ranked 3/10), so we categorized them as separate brands. TheraTears (Akorn Inc, Ann Arbor, MI) (ranked 6/10) and Optisource (Nestle HealthCare Nutrition, Florham Park, NJ; ranked 7/10) were omitted from our study, because these brands did not manufacture products that were marketed to provide nutritional support for eye health.
Our analysis includes all the ocular nutritional supplements manufactured by the 5 top-selling ocular nutritional supplement brands. Table 1 lists the 11 ocular nutritional supplements reviewed, their ingredients, and manufacturer claims. The ingredients were compared with the original AREDS (500 mg of vitamin C, 400 IU of vitamin E, 15 mg of beta-carotene, 80 mg of zinc, and 2 mg of copper) and the AREDS2 (500 mg of vitamin C, 400 IU of vitamin E, 10 mg of lutein, 2 mg of zeaxanthin, 80 mg of zinc, and 2 mg of copper) formulae. We obtained information about ingredients and manufacturer claims from the companies’ consumer information websites.101112 and 13
Table 1.

The Top Selling Eye Supplement Brands in the United States, June 2011 to June 2012
Brand (Company) Product Compared with AREDSIngredients Compared with AREDS/AREDS2Doses Manufacturer Claims
PreserVision (Bausch & Lomb, Rochester, NY) PreserVision Eye Vitamin AREDS Formula Tablets Same Same “The one and only vitamin and mineral supplement formula proven effective in the National Eye Institute’s AREDS”9
“Proven to reduce the risk of progression in people with moderate-to-advanced AMD in the National Eye Institute’s AREDS”9
PreserVision Eye Vitamin AREDS Formula Soft Gels Same Same “Based on the original Bausch & Lomb PreserVision Eye Vitamin AREDS Formula”9
PreserVision Eye Vitamin Lutein Formula Soft Gels − Beta-carotene
+ Lutein
Same “AREDS-based formula that replaces beta-carotene with lutein. For those who should avoid beta-carotene, such as smokers”9
PreserVision AREDS2 Formula − Beta-carotene
+ Lutein
+ Zeaxanthin
Same “Builds on the original, clinically proven PreserVision AREDS formula”9
Ocuvite (Bausch & Lomb) Ocuvite Eye Vitamin Adult 50+ Formula − Beta-carotene
+ Lutein
+ Zeaxanthin
+ Omega-3 fatty acids
30% of vitamin C
7.5% of vitamin E
50% of lutein
50% of zeaxanthin
11% of zinc
50% of copper
“Many people are not getting high levels of many important eye nutrients through diet alone”10
“Help replenish the vital nutrients your eyes can lose as you age”; “unique formula to help protect your eye health”10
“Important for proper retinal function and support overall eye health”10
“Important to help maintain eye health”10
Ocuvite Lutein and Zeaxanthin Eye Vitamin and Mineral Supplements − Beta-carotene
+ Lutein
+ Zeaxanthin
12% of vitamin C
7.5% of vitamin E
50% of lutein/zeaxanthin
19% of zinc
100% copper
“Help replenish essential nutrients to help protect the health of your eyes”10
“Supports macular health by helping filter harmful blue light”10
“Helps keep the macula of the eye healthy, and the macula is critical to your vision”10
“As we age, lutein is depleted and must be constantly replaced”10
Ocuvite Lutein Eye Vitamin and Mineral Supplement + Lutein
+ Selenium
40% of vitamin C
15% of vitamin E
4% of beta-carotene
20% of lutein
50% of zinc
100% copper
“Work to help protect the health of your eyes”10
“Supports macular health by helping filter harmful blue light”10
ICaps (Alcon Laboratories, Fort Worth, TX) ICaps Eye Vitamin Lutein & Omega-3 Formula + Vitamin A as retinol
(−beta-carotene)
+ Vitamin B1, B2, B3, B6, B9, B12
+ Calcium
+ Selenium
+ Manganese
+ Lutein
+ Zeaxanthin
+ Omega-3 fatty acids
9% of vitamin C
3% of vitamin E
100% of lutein
100% of zeaxanthin
9% of zinc
45% of copper
“Promotes healthy eyes in people at risk for age-related eye changes”11
ICaps Eye Vitamin Lutein & Zeaxanthin Formula + Riboflavin
+ Manganese
+ Selenium
+ Calcium
80% of vitamin C
38% of vitamin E
26% of beta- carotene
33% of lutein/zeaxanthin
75% of zinc
200% of copper
“Provides lutein with zeaxanthin to support eye health”11
“Recommended for people who are interested in overall eye health”11
“For people who want to supplement their current multivitamin or are not currently taking a multivitamin”11
ICaps AREDS (Alcon Laboratories) ICaps Eye Vitamin AREDS Formula Same Same “Contains the exact formulation used in the AREDS”11
“Supports eye health in people with intermediate to advanced AMD”11
EyeScience Macular Health Formula (EyeScience, Powell, OH) EyeScience Macular Health Formula + Vitamin D
+ Selenium
+ Vitamin B6, B9
+ Lutein
+ Zeaxanthin
+ Bilberry extract
+ Alpha lipoic acid
+ Grapeseed extract
+ L-Glutathione
+ MacuGlo (EyeScience) proprietary blend
100% of vitamin C
100% of vitamin E
100% of lutein
100% of zeaxanthin
50% of zinc
100% of copper
“The most complete ocular supplement designed for those with and without AMD”12
“For older patients who may already be at an increased risk for AMD, it is better late than never when it comes to the use of nutraceuticals”12
Per Packaged Facts (Rockville, MD).
AREDS (500 mg of vitamin C, 400 IU of vitamin E, 15 mg of beta-carotene, 80 mg of zinc, 2 mg of copper).
AREDS2 (500 mg of vitamin C, 400 IU of vitamin E, 10 mg of lutein, 2 mg of zeaxanthin, 80 mg of zinc, 2 mg of copper).

Results

All of the ocular nutritional supplements contained the ingredients from the AREDS or AREDS2 formula. Four of the 11 supplements (36%) contained equivalent doses of AREDS or AREDS2 ingredients; three supplements duplicated the original AREDS formula, and 1 supplement substituted beta-carotene with lutein and zeaxanthin, duplicating the AREDS2 formula.3 One supplement (9%) substituted beta-carotene with lutein only. Four supplements (36%) contained lower doses of all of the AREDS or AREDS2 ingredients (excluding copper). One supplement (9%) added lutein to the AREDS formula but had lower doses of all the other ingredients. One supplement (9%) had a lower dose of just 1 AREDS ingredient: EyeScience Macular Health Formula (EyeScience, Powell, OH) contained 50% of the AREDS zinc dose. Four of the supplements (36%) included additional ingredients to the AREDS formula, such as omega-3 fatty acids, non-AREDS vitamins, non-AREDS minerals, and herbal extracts.
All 5 brands used product descriptions classified by the Food and Drug Administration’s A Dietary Supplement Labeling Guide as Structure/Function Claims, which describe the role of a nutrient intended to affect the structure or function of the body. 14 Only PreserVision and ICaps brands specified that their supplements were beneficial for patients with AMD and included that their supplements were beneficial for patients with “intermediate to advanced AMD” or “moderate to advanced AMD.”
All the individual supplements claimed to “support,” “protect,” “help,” or “promote” vision and eye health, but none specified that there is no proven benefit in using nutritional supplements for primary prevention of eye disease. Six of the 11 supplements (55%) included some information about AREDS on their consumer information websites. Product descriptions of 4 of the 11 supplements (36%) stated that taking a supplement is important to maintain general eye health; none of these contained the exact doses of the AREDS or AREDS2 formula.

Discussion

This study examined the 5 top-selling ocular nutritional supplement brands in the United States and found that although 100% of these supplements contained the ingredients in the AREDS or AREDS2 formula, only 36% (4/11) duplicated the AREDS or AREDS2 formula. Of note, Bausch & Lomb holds patents to both AREDS (2003) and AREDS2 formulae (2013).15 and 16 This does not change the fact that the product descriptions of half of the products included claims that are not supported by level 1 evidence.17 This may be particularly confusing to the elderly, who comprise the majority of supplement users.18 Indeed, more than half of the supplements in our analysis had product descriptions that claimed that their formula was based on AREDS, but only 2 brands specified that the reduced risk of disease progression was in patients with intermediate to advanced AMD.
Under the Dietary Supplement Health and Education Act of 1994, dietary supplements are not evaluated or regulated for efficacy or safety.19 Approval from the Food and Drug Administration is not required for manufacturers to market dietary supplements.19 Use of ocular nutritional supplements is associated with several potential side effects and risks. Of note, there was an increase in genitourinary hospitalizations and self-reported anemia (although measured hematocrits were similar) associated with the use of the AREDS formula.2 Also, beta-carotene may increase the risk of lung cancer in current smokers.20 In addition, the daily dose of vitamin E in the AREDS formulation may increase the risk of prostate cancer among men with high baseline levels of selenium.21 Finally, simultaneous administration of beta-carotene and lutein may suppress serum and tissue levels of carotenoids because of interactions in metabolism and clearance from competitive absorption.22

Study Limitations

There are limitations that may affect the rank list of brands of ocular supplements used in this study. First, this analysis was conducted with sales data dating before AREDS2.3 Second, the SymphonyIRI data excluded sales from Walmart, which has the highest revenue of any retail corporation in the United States.23
Although both AREDS and AREDS2 demonstrated the association between exposure to certain nutrients and a reduced risk of progression to and visual loss from advanced AMD, these studies do not address the optimal dose and choice of carotenoids.24 We have not included in our analysis evidence clinicians may find useful to educate patients, such as studies demonstrating the potential visual benefits of supplementation with other nutrients, the potential for nutrient supplementation to reduce progression of other disease processes, such as age-related cataracts, or the potential reduction of ocular disease with a healthy diet.4252627282930 and 31
In conclusion, this analysis underscores the importance of ophthalmologists educating their patients on the evidence-based role of nutritional supplements in the management of eye health.

References

    • 1
    • Multi-Sponsor Surveys Inc. 2011 Gallup Study of U.S. Eye Health. April 2011.
    • 2
    • Age-Related Eye Disease Study Research Group
    • A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
    • Arch Ophthalmol, 119 (2001), pp. 1417–1430
    • 3
    • Age-Related Eye Disease Study 2 (AREDS2) Research Group
    • Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial
    • JAMA, 309 (2013), pp. 2005–2012
    • 4
    • J.R. Evans, J.G. Lawrenson
    • Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
    • Cochrane Database Syst Rev, 6 (2012), p. CD000253
    •  | 

    • 5
    • Age-Related Eye Disease Study Research Group
    • A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9
    • Arch Ophthalmol, 119 (2001), pp. 1439–1452
    • 7
    • S.P. Fortmann, B.U. Burda, C.A. Senger, et al.
    • Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systemic evidence review for the U.S. Preventative Services Task Force
    • Ann Intern Med, 159 (2013), pp. 824–834
    •  | 

    • 9
    • Nutritional Supplements in the U.S (5th ed.)Packaged Facts, Rockville, MD (2012)
    • 18
    • J. Gahche, R. Bailey, V. Burt, et al.
    • Dietary supplement use among U.S. adults has increased since NHANES III (1988–1994)
    • NCHS Data Brief (61) (2011), pp. 1–8
    •  | 

    • 21
    • A.R. Kristal, A.K. Darke, J.S. Morris, et al.
    • Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk
    • J Natl Cancer Inst, 106 (2014), p. djt456
    • 22
    • D. Kostic, W.S. White, J.A. Olson
    • Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses
    • Am J Clin Nutr, 62 (1995), pp. 604–610
    •  | 

    • 26
    • Clinical Trial of Nutritional Supplements and Age-Related Cataract Study Group
    • A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities: Clinical Trial of Nutritional Supplements and Age-Related Cataract report no. 3
    • Ophthalmology, 115 (2008), pp. 599–607
Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
This material is the result of work supported with resources and the use of facilities at the Providence VA Medical Center. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the U.S. government.
Correspondence: Paul B. Greenberg, MD, Section of Ophthalmology, Providence VA Medical Center, 830 Chalkstone Ave, Providence, RI 02908.
Shopping Cart